IMA vs LYFT · rev $9.2M vs P/E 108, rev $5.79B
ImageneBio, Inc. (IMA) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
IMA currently screens at market cap $64.7M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the IMA and LYFT stock pages for the full models.
Not investment advice.